Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.

Subjects

Subjects :

Amputation, Surgical statistics & numerical data
Humans
Interferon-gamma administration & dosage
Melphalan administration & dosage
Multicenter Studies as Topic
Sarcoma surgery
Survival Analysis
Tumor Necrosis Factor-alpha administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Extremities
Sarcoma drug therapy
Sarcoma secondary

Details

Language :

English

ISSN :

0732-183X

Volume :

15

Issue :

5

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

9164235

Full Text :

https://doi.org/10.1200/JCO.1997.15.5.2174